Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC29339022;9023;9024 chr2:178769784;178769783;178769782chr2:179634511;179634510;179634509
N2AB29339022;9023;9024 chr2:178769784;178769783;178769782chr2:179634511;179634510;179634509
N2A29339022;9023;9024 chr2:178769784;178769783;178769782chr2:179634511;179634510;179634509
N2B28878884;8885;8886 chr2:178769784;178769783;178769782chr2:179634511;179634510;179634509
Novex-128878884;8885;8886 chr2:178769784;178769783;178769782chr2:179634511;179634510;179634509
Novex-228878884;8885;8886 chr2:178769784;178769783;178769782chr2:179634511;179634510;179634509
Novex-329339022;9023;9024 chr2:178769784;178769783;178769782chr2:179634511;179634510;179634509

Information

  • RefSeq wild type amino acid: G
  • RefSeq wild type transcript codon: GGA
  • RefSeq wild type template codon: CCT
  • Domain: Ig-19
  • Domain position: 52
  • Structural Position: 131
  • Q(SASA): 0.1837
  • Predicted PPI site: N

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
G/E rs1406534791 None 1.0 D 0.675 0.729 0.77929513315 gnomAD-4.0.0 1.20032E-06 None None None None N None 0 0 None 0 0 None 0 0 1.3125E-06 0 0

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
G/A 0.94 likely_pathogenic 0.8377 pathogenic -0.514 Destabilizing 1.0 D 0.591 neutral D 0.665795385 None None N
G/C 0.9837 likely_pathogenic 0.9425 pathogenic -0.606 Destabilizing 1.0 D 0.655 neutral None None None None N
G/D 0.9495 likely_pathogenic 0.8292 pathogenic -1.084 Destabilizing 1.0 D 0.685 prob.neutral None None None None N
G/E 0.9729 likely_pathogenic 0.8975 pathogenic -1.154 Destabilizing 1.0 D 0.675 neutral D 0.663150778 None None N
G/F 0.9972 likely_pathogenic 0.9934 pathogenic -0.905 Destabilizing 1.0 D 0.643 neutral None None None None N
G/H 0.9936 likely_pathogenic 0.9771 pathogenic -1.133 Destabilizing 1.0 D 0.641 neutral None None None None N
G/I 0.9965 likely_pathogenic 0.9911 pathogenic -0.24 Destabilizing 1.0 D 0.645 neutral None None None None N
G/K 0.9932 likely_pathogenic 0.9765 pathogenic -1.206 Destabilizing 1.0 D 0.675 prob.neutral None None None None N
G/L 0.9944 likely_pathogenic 0.9846 pathogenic -0.24 Destabilizing 1.0 D 0.681 prob.neutral None None None None N
G/M 0.9952 likely_pathogenic 0.9865 pathogenic -0.229 Destabilizing 1.0 D 0.654 neutral None None None None N
G/N 0.96 likely_pathogenic 0.8663 pathogenic -0.783 Destabilizing 1.0 D 0.703 prob.neutral None None None None N
G/P 0.999 likely_pathogenic 0.9973 pathogenic -0.292 Destabilizing 1.0 D 0.666 neutral None None None None N
G/Q 0.9864 likely_pathogenic 0.9483 pathogenic -0.969 Destabilizing 1.0 D 0.661 neutral None None None None N
G/R 0.988 likely_pathogenic 0.9558 pathogenic -0.848 Destabilizing 1.0 D 0.659 neutral D 0.67577457 None None N
G/S 0.8739 likely_pathogenic 0.6363 pathogenic -0.942 Destabilizing 1.0 D 0.698 prob.neutral None None None None N
G/T 0.9835 likely_pathogenic 0.9481 pathogenic -0.942 Destabilizing 1.0 D 0.672 neutral None None None None N
G/V 0.9912 likely_pathogenic 0.976 pathogenic -0.292 Destabilizing 1.0 D 0.685 prob.neutral D 0.726824229 None None N
G/W 0.9887 likely_pathogenic 0.9745 pathogenic -1.284 Destabilizing 1.0 D 0.644 neutral None None None None N
G/Y 0.9913 likely_pathogenic 0.9766 pathogenic -0.863 Destabilizing 1.0 D 0.645 neutral None None None None N

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.